Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Structure, Regulation, Signaling, and Targeting of Abl Kinases in Cancer - Oliver Hantschel, 2012
JCI - Applying the discovery of the Philadelphia chromosome
BCR-ABL activates multiple downstream signaling pathways that... | Download Scientific Diagram
Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeutics: Cancer Cell
A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. - Australian Medical Student Journal
Frontiers | Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis: Cell
Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Dasatinib is an Orally Active Dual Bcr-Abl and Src Family Tyrosine Kinase Inhibitor | MedChemExpress
Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews Drug Discovery
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
![PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7afde5a58c37047c83cde7051c4024ff35912884/2-Figure1-1.png "PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar")
PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
Bcr-Abl阻害 | Bcr-Abl Inhibition
Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram
IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram
Response and Resistance to BCR-ABL1-Targeted Therapies
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach
